0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Human Immunodeficiency Virus–Induced Interferon-Stimulated Gene Expression Is Associated With Monocyte Activation and Predicts Viral Load

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Chronic immune activation is one of the hallmarks of human immunodeficiency virus (HIV) pathogenesis. Persistent upregulation of interferons (IFNs) and interferon-stimulated genes (ISGs) has previously been associated with chronic immune activation and HIV progression. Here a longitudinal analysis of the IFN and ISG response during HIV infection was performed to gain insights into the ongoing immune activation during HIV infection.

          Methods

          IFN and ISG levels were determined using quantitative polymerase chain reaction in peripheral blood mononuclear cells of people with HIV at pre-seroconversion, during acute and chronic HIV infection, and during suppressive antiretroviral therapy (ART).

          Results

          HIV infection induced the expression of a set of 4 ISGs—RSAD2, ISG15, IFI44L, and IFI27—which remained upregulated during chronic infection. This set of ISGs showed no clear correlations with T-cell activation as determined by co-expression of CD38 and HLA-DR. However, a strong correlation with monocyte activation marker soluble CD163 in serum was found. Furthermore, the expression of this ISG cluster was predictive of viral load before ART initiation and, on ART, expression levels normalized to pre-seroconversion levels.

          Conclusions

          The results presented here suggests that ISG expression is linked to monocyte activation, possibly driven by viral replication.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Interferon-stimulated genes: a complex web of host defenses.

          Interferon-stimulated gene (ISG) products take on a number of diverse roles. Collectively, they are highly effective at resisting and controlling pathogens. In this review, we begin by introducing interferon (IFN) and the JAK-STAT signaling pathway to highlight features that impact ISG production. Next, we describe ways in which ISGs both enhance innate pathogen-sensing capabilities and negatively regulate signaling through the JAK-STAT pathway. Several ISGs that directly inhibit virus infection are described with an emphasis on those that impact early and late stages of the virus life cycle. Finally, we describe ongoing efforts to identify and characterize antiviral ISGs, and we provide a forward-looking perspective on the ISG landscape.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Type I interferons in infectious disease.

            Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interferon-Stimulated Genes: What Do They All Do?

              In the absence of an intact interferon (IFN) response, mammals may be susceptible to lethal viral infection. IFNs are secreted cytokines that activate a signal transduction cascade leading to the induction of hundreds of interferon-stimulated genes (ISGs). Remarkably, approximately 10% of the genes in the human genome have the potential to be regulated by IFNs. What do all of these genes do? It is a complex question without a simple answer. From decades of research, we know that many of the protein products encoded by these ISGs work alone or in concert to achieve one or more cellular outcomes, including cell intrinsic antiviral defense, antiproliferative activities, and stimulation of adaptive immunity. The focus of this review is the antiviral activities of the IFN/ISG system. This includes general paradigms of ISG function, supported by specific examples in the literature, as well as methodologies to identify and characterize ISG function. Expected final online publication date for the Annual Review of Virology Volume 6 is September 30, 2019. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
                Bookmark

                Author and article information

                Contributors
                Journal
                Open Forum Infect Dis
                Open Forum Infect Dis
                ofid
                Open Forum Infectious Diseases
                Oxford University Press (US )
                2328-8957
                August 2024
                05 August 2024
                05 August 2024
                : 11
                : 8
                : ofae434
                Affiliations
                Amsterdam Institute for Infection and Immunity , Amsterdam, The Netherlands
                Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam , Amsterdam, The Netherlands
                Amsterdam Institute for Infection and Immunity , Amsterdam, The Netherlands
                Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam , Amsterdam, The Netherlands
                Amsterdam Institute for Infection and Immunity , Amsterdam, The Netherlands
                Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam , Amsterdam, The Netherlands
                Amsterdam Institute for Infection and Immunity , Amsterdam, The Netherlands
                Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam , Amsterdam, The Netherlands
                Amsterdam Institute for Infection and Immunity , Amsterdam, The Netherlands
                Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam , Amsterdam, The Netherlands
                Amsterdam Institute for Infection and Immunity , Amsterdam, The Netherlands
                Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam , Amsterdam, The Netherlands
                Author notes
                Correspondence: Neeltje A. Kootstra, PhD, Amsterdam UMC, location AMC, Department of Experimental Immunology, Room M01-120, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands ( n.a.kootstra@ 123456amsterdamumc.nl ).

                Potential conflicts of interest. All authors: No reported conflicts of interest.

                Author information
                https://orcid.org/0000-0001-9429-7754
                Article
                ofae434
                10.1093/ofid/ofae434
                11298257
                39104769
                1b5f16f3-5f5e-4edb-9d21-07052a36ff5a
                © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 27 March 2024
                : 18 July 2024
                : 05 August 2024
                Page count
                Pages: 9
                Funding
                Funded by: Aids Fonds, DOI 10.13039/100007553;
                Award ID: P-37202
                Categories
                Global Health and Infectious Diseases
                Major Article
                AcademicSubjects/MED00290

                hiv,immune activation,innate immune response,isg,monocyte
                hiv, immune activation, innate immune response, isg, monocyte

                Comments

                Comment on this article